{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:07:20Z","timestamp":1790712440544,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05480-9","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:20:00Z","timestamp":1790709600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sildenafil in bronchopulmonary dysplasia-associated pulmonary hypertension: developmental and translational insights"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4682-3999","authenticated-orcid":false,"given":"Jenyfer","family":"Fuentes-Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5622-4558","authenticated-orcid":false,"given":"Mateo","family":"Sernaqu\u00e9-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5506-7775","authenticated-orcid":false,"given":"Daniela","family":"Cruz-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-8261","authenticated-orcid":false,"given":"Carlos","family":"Zavaleta-Corvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-3351","authenticated-orcid":false,"given":"Angel","family":"Samanez-Obeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"5480_CR1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/s41390-022-02428-7","volume":"96","author":"W Durlak","year":"2024","unstructured":"Durlak, W. & Th\u00e9baud, B. The vascular phenotype of BPD: new basic science insights-new precision medicine approaches. Pediatr. Res. 96, 1162\u20131171 https:\/\/doi.org\/10.1038\/s41390-022-02428-7 (2024).","journal-title":"Pediatr. Res."},{"key":"5480_CR2","doi-asserted-by":"publisher","first-page":"151817","DOI":"10.1016\/j.semperi.2023.151817","volume":"47","author":"A El-Saie","year":"2023","unstructured":"El-Saie, A. et al. Webb MK Bronchopulmonary dysplasia - associated pulmonary hypertension: an updated review. Semin Perinatol. 47, 151817 https:\/\/doi.org\/10.1016\/j.semperi.2023.151817 (2023).","journal-title":"Semin Perinatol."},{"key":"5480_CR3","doi-asserted-by":"publisher","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","volume":"53","author":"EB Rosenzweig","year":"2019","unstructured":"Rosenzweig, E. B. et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur. Respir. J. 53, 1801916 https:\/\/doi.org\/10.1183\/13993003.01916-2018 (2019).","journal-title":"Eur. Respir. J."},{"key":"5480_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/archdischild-2024-327169","volume":"110","author":"MS Akin","year":"2025","unstructured":"Akin, M. S. et al. Association between early pulmonary arterial pressure measurements and bronchopulmonary dysplasia or mortality in very preterm infants: a prospective cohort study. Arch. Dis. Child Fetal Neonatal Ed. 110, 291\u2013296 https:\/\/doi.org\/10.1136\/archdischild-2024-327169 (2025).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"5480_CR5","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1002\/ppul.25602","volume":"56","author":"KW Malloy","year":"2021","unstructured":"Malloy, K. W. & Austin, E. D. Pulmonary hypertension in the child with bronchopulmonary dysplasia. Pediatr. Pulmonol. 56, 3546\u20133556 https:\/\/doi.org\/10.1002\/ppul.25602 (2021).","journal-title":"Pediatr. Pulmonol."},{"key":"5480_CR6","doi-asserted-by":"publisher","first-page":"H702","DOI":"10.1152\/ajpheart.00021.2022","volume":"322","author":"H Christou","year":"2022","unstructured":"Christou, H. & Khalil, R. A. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. Am. J. Physiol. Heart Circ. Physiol. 322, H702\u2013H724 https:\/\/doi.org\/10.1152\/ajpheart.00021.2022 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"5480_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/HCO.0000000000001228","volume":"40","author":"K Parikh","year":"2025","unstructured":"Parikh, K. Pulmonary hypertension in 2025: next steps. Curr. Opin. Cardiol. 40, 251\u2013258 https:\/\/doi.org\/10.1097\/HCO.0000000000001228 (2025).","journal-title":"Curr. Opin. Cardiol."},{"key":"5480_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1047951124025976","volume":"35","author":"KR Kumar","year":"2025","unstructured":"Kumar, K. R. et al. Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants. Cardiol. Young. 35, 93\u2013101 https:\/\/doi.org\/10.1017\/S1047951124025976 (2025).","journal-title":"Cardiol. Young."},{"key":"5480_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.12865\/CHSJ.49.03.03","volume":"49","author":"I Branescu","year":"2023","unstructured":"Branescu, I., Vladareanu, S., Shetty, S., Alexandru, D. O. & Kulkarni, A. Sildenafil in pulmonary hypertension associated with bronchopulmonary dysplasia: friend or foe?. Curr. Health Sci. J. 49, 319\u2013324 https:\/\/doi.org\/10.12865\/CHSJ.49.03.03 (2023).","journal-title":"Curr. Health Sci. J."},{"key":"5480_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1165\/rcmb.2020-0434OC","volume":"65","author":"M Sharma","year":"2021","unstructured":"Sharma, M. et al. Decreased cyclic guanosine monophosphate-protein kinase G signaling impairs angiogenesis in a lamb model of persistent pulmonary hypertension of the newborn. Am. J. Respir. Cell Mol. Biol. 65, 555\u2013567 https:\/\/doi.org\/10.1165\/rcmb.2020-0434OC (2021).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"5480_CR11","doi-asserted-by":"publisher","first-page":"115373","DOI":"10.1016\/j.fct.2025.115373","volume":"200","author":"WAI Khallaf","year":"2025","unstructured":"Khallaf, W. A. I. et al. Sildenafil abrogates radiation-induced hepatotoxicity in animal model: the impact of NF-\u03baB-p65, P53, Nrf2, and SIRT 1 pathway. Food Chem. Toxicol. Int J. Publ. Br. Ind. Biol. Res Assoc. 200, 115373 https:\/\/doi.org\/10.1016\/j.fct.2025.115373 (2025).","journal-title":"Food Chem. Toxicol. Int J. Publ. Br. Ind. Biol. Res Assoc."},{"key":"5480_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpeds.2018.09.067","volume":"205","author":"JL Cohen","year":"2019","unstructured":"Cohen, J. L., Nees, S. N., Valencia, G. A., Rosenzweig, E. B. & Krishnan, U. S. Sildenafil use in children with pulmonary hypertension. J. Pediatr. 205, 29\u201334.e1 https:\/\/doi.org\/10.1016\/j.jpeds.2018.09.067 (2019).","journal-title":"J. Pediatr."},{"key":"5480_CR13","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/14656566.2024.2383628","volume":"25","author":"T Oluwole-Ojo","year":"2024","unstructured":"Oluwole-Ojo, T., Harris, C. & Greenough, A. Advances in the pharmacological management of bronchopulmonary dysplasia: an update of the literature. Expert Opin. Pharmacother. 25, 1349\u20131358 https:\/\/doi.org\/10.1080\/14656566.2024.2383628 (2024).","journal-title":"Expert Opin. Pharmacother."},{"key":"5480_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00395-020-0811-5","volume":"115","author":"MP Winter","year":"2020","unstructured":"Winter, M. P. et al. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension. Basic Res Cardiol. 115, 58 https:\/\/doi.org\/10.1007\/s00395-020-0811-5 (2020).","journal-title":"Basic Res Cardiol."},{"key":"5480_CR15","doi-asserted-by":"publisher","unstructured":"Mathew, R. Signaling pathways involved in the development of bronchopulmonary dysplasia and pulmonary hypertension. Children 7, https:\/\/doi.org\/10.3390\/children7080100 (2020).","DOI":"10.3390\/children7080100"},{"key":"5480_CR16","doi-asserted-by":"publisher","first-page":"2387465","DOI":"10.1080\/13510002.2024.2387465","volume":"29","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Hyperoxia exposure induces ferroptosis and apoptosis by downregulating PLAGL2 and repressing HIF-1\u03b1\/VEGF signaling pathway in newborn alveolar typeII epithelial cell. Redox Rep. Commun. Free Radic. Res. 29, 2387465 https:\/\/doi.org\/10.1080\/13510002.2024.2387465 (2024).","journal-title":"Redox Rep. Commun. Free Radic. Res."},{"key":"5480_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1165\/rcmb.2024-0544OC","volume":"73","author":"LC Wickramasinghe","year":"2025","unstructured":"Wickramasinghe, L. C. et al. VEGF-D protects the lung in neonatal hyperoxia-induced lung injury. Am. J. Respir. Cell Mol. Biol. 73, 790\u2013804 https:\/\/doi.org\/10.1165\/rcmb.2024-0544OC (2025).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"5480_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/14767058.2020.1760826","volume":"35","author":"J Mariduena","year":"2022","unstructured":"Mariduena, J. et al. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants. J. Matern Fetal Neonatal Med. 35, 1517\u20131522 https:\/\/doi.org\/10.1080\/14767058.2020.1760826 (2022).","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"5480_CR19","doi-asserted-by":"publisher","first-page":"2202445","DOI":"10.1183\/13993003.02445-2022","volume":"62","author":"F H\u00e4fner","year":"2023","unstructured":"H\u00e4fner, F. et al. MRI pulmonary artery flow detects lung vascular pathology in preterms with lung disease. Eur. Respir. J. 62, 2202445 https:\/\/doi.org\/10.1183\/13993003.02445-2022 (2023).","journal-title":"Eur. Respir. J."},{"key":"5480_CR20","doi-asserted-by":"publisher","unstructured":"Chakr V. G. et al. Early echocardiographic indicators of pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Pediatr. Cardiol. https:\/\/doi.org\/10.1007\/s00246-025-04079-x (2025).","DOI":"10.1007\/s00246-025-04079-x"},{"key":"5480_CR21","doi-asserted-by":"publisher","first-page":"204589401881606","DOI":"10.1177\/2045894018816063","volume":"9","author":"AJ Blanca","year":"2019","unstructured":"Blanca, A. J. et al. Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study. Pulm. Circ. 9, 2045894018816063 https:\/\/doi.org\/10.1177\/2045894018816063 (2019).","journal-title":"Pulm. Circ."},{"key":"5480_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11936-019-0713-8","volume":"21","author":"S Bhattacharya","year":"2019","unstructured":"Bhattacharya, S., Sen, S., Levy, P. T. & Rios, D. R. Comprehensive evaluation of right heart performance and pulmonary hemodynamics in neonatal pulmonary hypertension: evaluation of cardiopulmonary performance in neonatal pulmonary hypertension. Curr. Treat. Options Cardiovasc. Med. 21, 10 https:\/\/doi.org\/10.1007\/s11936-019-0713-8 (2019).","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"5480_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41390-023-02522-4","volume":"94","author":"H Nawaytou","year":"2023","unstructured":"Nawaytou, H., Hills, N. K. & Clyman, R. I. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension. Pediatr. Res. 94, 547\u2013554 https:\/\/doi.org\/10.1038\/s41390-023-02522-4 (2023).","journal-title":"Pediatr. Res."},{"key":"5480_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/FJC.0000000000001373","volume":"81","author":"L Kang","year":"2023","unstructured":"Kang, L. et al. Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn. J. Cardiovasc. Pharmacol. 81, 232\u2013239 https:\/\/doi.org\/10.1097\/FJC.0000000000001373 (2023).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"5480_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/HYPERTENSIONAHA.118.11932","volume":"73","author":"B Li","year":"2019","unstructured":"Li, B. et al. Targeted delivery of sildenafil for inhibiting pulmonary vascular remodeling. Hypertension 73, 703\u2013711 https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11932 (2019).","journal-title":"Hypertension"},{"key":"5480_CR26","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules27123724","volume":"27","author":"D Xu","year":"2022","unstructured":"Xu, D. et al. Oxidative stress and antioxidative therapy in pulmonary arterial hypertension. Molecules 27, 3724 https:\/\/doi.org\/10.3390\/molecules27123724 (2022).","journal-title":"Molecules"},{"key":"5480_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/fcp.12633","volume":"35","author":"M Ala","year":"2021","unstructured":"Ala, M., Mohammad Jafari, R. & Dehpour, A. R. Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: thinking about new indications. Fundam. Clin. Pharmacol. 35, 235\u2013259 https:\/\/doi.org\/10.1111\/fcp.12633 (2021).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"5480_CR28","doi-asserted-by":"publisher","first-page":"230183","DOI":"10.1183\/16000617.0183-2023","volume":"33","author":"RL Benza","year":"2024","unstructured":"Benza, R. L., Gr\u00fcnig, E., Sandner, P., Stasch, J. P. & Simonneau, G. The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase. Eur. Respir. Rev. J. Eur. Respir. Soc. 33, 230183 https:\/\/doi.org\/10.1183\/16000617.0183-2023 (2024).","journal-title":"Eur. Respir. Rev. J. Eur. Respir. Soc."},{"key":"5480_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12887-019-1801-3","volume":"19","author":"K Lavie-Nevo","year":"2019","unstructured":"Lavie-Nevo, K., Harris, K. C. & Ting, J. Y. Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia \u2013 a case report. BMC Pediatr. 19, 416 https:\/\/doi.org\/10.1186\/s12887-019-1801-3 (2019).","journal-title":"BMC Pediatr."},{"key":"5480_CR30","doi-asserted-by":"publisher","first-page":"767002","DOI":"10.3389\/fphar.2021.767002","volume":"12","author":"A Tettey","year":"2021","unstructured":"Tettey, A., Jiang, Y., Li, X. & Li, Y. Therapy for pulmonary arterial hypertension: glance on nitric oxide pathway. Front. Pharmacol. 12, 767002 https:\/\/doi.org\/10.3389\/fphar.2021.767002 (2021).","journal-title":"Front. Pharmacol."},{"key":"5480_CR31","doi-asserted-by":"publisher","unstructured":"Francis, B. N., Salameh, M., Khamisy-Farah, R. & Farah, R. Tetrahydrobiopterin (BH4): targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertension. Cardiovasc. Ther. 36, https:\/\/doi.org\/10.1111\/1755-5922.12312 (2018).","DOI":"10.1111\/1755-5922.12312"},{"key":"5480_CR32","doi-asserted-by":"publisher","first-page":"7090534","DOI":"10.1155\/2019\/7090534","volume":"2019","author":"Q Liu","year":"2019","unstructured":"Liu, Q., Gao, Y. & Ci, X. Role of Nrf2 and its activators in respiratory diseases. Oxid. Med. Cell Longev. 2019, 7090534 https:\/\/doi.org\/10.1155\/2019\/7090534 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"5480_CR33","doi-asserted-by":"publisher","unstructured":"Kosutova, P. et al. Effects of phosphodiesterase 5 inhibitor sildenafil on the respiratory parameters, inflammation and apoptosis in a saline lavage-induced model of acute lung injury. J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc. 69, https:\/\/doi.org\/10.26402\/jpp.2018.5.15 (2019).","DOI":"10.26402\/jpp.2018.5.15"},{"key":"5480_CR34","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1080\/14656566.2023.2257598","volume":"24","author":"MF Pizzuto","year":"2023","unstructured":"Pizzuto, M. F., Laughon, M. M. & Jackson, W. M. Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants. Expert Opin. Pharmacother. 24, 1875\u20131886 https:\/\/doi.org\/10.1080\/14656566.2023.2257598 (2023).","journal-title":"Expert Opin. Pharmacother."},{"key":"5480_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41372-026-02578-0","volume":"5","author":"KR Gopagondanahalli","year":"2026","unstructured":"Gopagondanahalli, K. R. et al. Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension. J. Perinatol. 5, 1\u20137 https:\/\/doi.org\/10.1038\/s41372-026-02578-0 (2026).","journal-title":"J. Perinatol."},{"key":"5480_CR36","doi-asserted-by":"publisher","first-page":"e193975","DOI":"10.1172\/jci.insight.193975","volume":"10","author":"M Sharma","year":"2025","unstructured":"Sharma, M. et al. Defining endotypes of bronchopulmonary dysplasia in preterm infants to improve precision-based therapies. JCI Insight 10, e193975 https:\/\/doi.org\/10.1172\/jci.insight.193975 (2025).","journal-title":"JCI Insight"},{"key":"5480_CR37","doi-asserted-by":"publisher","first-page":"998","DOI":"10.21037\/tp-20-277","volume":"10","author":"Z Li","year":"2021","unstructured":"Li, Z., Lv, X., Liu, Q., Dang, D. & Wu, H. Update on the use of sildenafil in neonatal pulmonary hypertension: a narrative review of the history, current administration, and future directions. Transl. Pediatr. 10, 998\u20131007 https:\/\/doi.org\/10.21037\/tp-20-277 (2021).","journal-title":"Transl. Pediatr."},{"key":"5480_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12887-020-02453-7","volume":"20","author":"S Schneider","year":"2020","unstructured":"Schneider, S. et al. Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study. BMC Pediatr. 20, 559 https:\/\/doi.org\/10.1186\/s12887-020-02453-7 (2020).","journal-title":"BMC Pediatr."},{"key":"5480_CR39","doi-asserted-by":"publisher","first-page":"960327126142042","DOI":"10.1177\/09603271261420421","volume":"45","author":"S Liang","year":"2026","unstructured":"Liang, S., Wang, X. & Wu, Y. Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications. Hum. Exp. Toxicol. 45, 9603271261420421 https:\/\/doi.org\/10.1177\/09603271261420421 (2026).","journal-title":"Hum. Exp. Toxicol."},{"key":"5480_CR40","doi-asserted-by":"publisher","first-page":"101025","DOI":"10.1016\/j.conctc.2022.101025","volume":"30","author":"JE Lang","year":"2022","unstructured":"Lang, J. E. et al. Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: rationale and methods of a phase II randomized trial. Contemp. Clin. Trials Commun. 30, 101025 https:\/\/doi.org\/10.1016\/j.conctc.2022.101025 (2022).","journal-title":"Contemp. Clin. Trials Commun."},{"key":"5480_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35387-y","volume":"13","author":"L Schroeder","year":"2023","unstructured":"Schroeder, L. et al. Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants. Sci. Rep. 13, 8405 https:\/\/doi.org\/10.1038\/s41598-023-35387-y (2023).","journal-title":"Sci. Rep."},{"key":"5480_CR42","doi-asserted-by":"publisher","first-page":"1195623","DOI":"10.3389\/fbioe.2023.1195623","volume":"11","author":"S Yoshida","year":"2023","unstructured":"Yoshida, S., Kreger, A. M. & Gittes, G. K. Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats. Front. Bioeng. Biotechnol. 11, 1195623 https:\/\/doi.org\/10.3389\/fbioe.2023.1195623 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"5480_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.4103\/sjamf.sjamf_72_20","volume":"4","author":"E Monazea","year":"2020","unstructured":"Monazea, E., Khattab, S., Ebrahim, A., Mohamed, L. & Ahmed, H. The outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn with respiratory distress. Sci. J. Al-Azhar Med. Fac. Girls 4, 535\u2013539 https:\/\/doi.org\/10.4103\/sjamf.sjamf_72_20 (2020).","journal-title":"Sci. J. Al-Azhar Med. Fac. Girls"},{"key":"5480_CR44","doi-asserted-by":"publisher","first-page":"220209","DOI":"10.1183\/20734735.0209-2022","volume":"18","author":"S Chan","year":"2022","unstructured":"Chan, S., Brugha, R., Quyam, S. & Moledina, S. Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists. Breathe 18, 220209 https:\/\/doi.org\/10.1183\/20734735.0209-2022 (2022).","journal-title":"Breathe"},{"key":"5480_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.24875\/BMHIM.20000041","volume":"77","author":"H M\u00e1rquez-Gonz\u00e1lez","year":"2020","unstructured":"M\u00e1rquez-Gonz\u00e1lez, H., R\u00edos, D. I., Jean Tron, M. G. & Barajas-Nava, L. A. Use of sildenafil for pulmonary hypertension in neonates. Bol. Med. Hosp. Infant Mex. 77, 202\u2013206 https:\/\/doi.org\/10.24875\/BMHIM.20000041 (2020).","journal-title":"Bol. Med. Hosp. Infant Mex."},{"key":"5480_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apa.70320","volume":"115","author":"JE Lang","year":"2026","unstructured":"Lang, J. E. & Hill, K. D. Chronic lung disease-related pulmonary hypertension in children. Acta Paediatr. 115, 16\u201331 https:\/\/doi.org\/10.1111\/apa.70320 (2026).","journal-title":"Acta Paediatr."},{"key":"5480_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41372-025-02317-x","volume":"45","author":"A Sehgal","year":"2025","unstructured":"Sehgal, A., Buckingham, M. R., Hyland, R. M. & McNamara, P. J. Diagnostic and therapeutic precision in cardiovascular diseases in the neonatal intensive care. J. Perinatol. 45, 888\u2013899 https:\/\/doi.org\/10.1038\/s41372-025-02317-x (2025).","journal-title":"J. Perinatol."},{"key":"5480_CR48","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41372-025-02309-x","volume":"45","author":"TF Vega","year":"2025","unstructured":"Vega, T. F. et al. Pulmonary vasodilator use in very preterm infants in United States children\u2019s hospitals. J. Perinatol. 45, 1382\u20131388 https:\/\/doi.org\/10.1038\/s41372-025-02309-x (2025).","journal-title":"J. Perinatol."},{"key":"5480_CR49","doi-asserted-by":"publisher","first-page":"e12305","DOI":"10.1002\/pul2.12305","volume":"13","author":"JM Collaco","year":"2023","unstructured":"Collaco, J. M. et al. Kids Mod PAH trial: a multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension. Pulm. Circ. 13, e12305 https:\/\/doi.org\/10.1002\/pul2.12305 (2023).","journal-title":"Pulm. Circ."},{"key":"5480_CR50","doi-asserted-by":"publisher","first-page":"204589401983787","DOI":"10.1177\/2045894019837875","volume":"9","author":"M van der Graaf","year":"2019","unstructured":"van der Graaf, M. et al. EXPRESS: Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. Pulm. Circ. 9, 2045894019837875 https:\/\/doi.org\/10.1177\/2045894019837875 (2019).","journal-title":"Pulm. Circ."},{"key":"5480_CR51","doi-asserted-by":"publisher","first-page":"e15749","DOI":"10.1111\/ped.15749","volume":"66","author":"K Hirata","year":"2024","unstructured":"Hirata, K. et al. Prophylactic sildenafil to prevent bronchopulmonary dysplasia: a systematic review and meta-analysis. Pediatr. Int. J. Jpn Pediatr. Soc. 66, e15749 https:\/\/doi.org\/10.1111\/ped.15749 (2024).","journal-title":"Pediatr. Int. J. Jpn Pediatr. Soc."},{"key":"5480_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.21037\/tp-20-192","volume":"10","author":"Y Du","year":"2021","unstructured":"Du, Y. et al. Echocardiography evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective observational cohort study. Transl. Pediatr. 10, 73\u201382 https:\/\/doi.org\/10.21037\/tp-20-192 (2021).","journal-title":"Transl. Pediatr."},{"key":"5480_CR53","doi-asserted-by":"publisher","unstructured":"H\u00e9bert, A. et al. Targeted neonatal echocardiography in bronchopulmonary dysplasia: a framework for screening and management of chronic pulmonary hypertension. J. Clin. Med. 14, https:\/\/doi.org\/10.3390\/jcm14228161 (2025).","DOI":"10.3390\/jcm14228161"},{"key":"5480_CR54","doi-asserted-by":"publisher","unstructured":"Dillon K., Lamba V., Philip R. R., Weems M. F. & Talati A. J. Efficacy of sildenafil in infants with bronchopulmonary dysplasia-associated pulmonary hypertension. Children. 10, https:\/\/doi.org\/10.3390\/children10081397 (2023).","DOI":"10.3390\/children10081397"},{"key":"5480_CR55","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1111\/bcp.14111","volume":"85","author":"D Gonzalez","year":"2019","unstructured":"Gonzalez, D. et al. Population pharmacokinetics of sildenafil in extremely premature infants. Br. J. Clin. Pharmacol. 85, 2824\u20132837 https:\/\/doi.org\/10.1111\/bcp.14111 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"5480_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11038-6","volume":"12","author":"SJ Rhee","year":"2022","unstructured":"Rhee, S. J. et al. Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension. Sci. Rep. 12, 7393 https:\/\/doi.org\/10.1038\/s41598-022-11038-6 (2022).","journal-title":"Sci. Rep."},{"key":"5480_CR57","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00112-025-02260-3","volume":"173","author":"M Koestenberger","year":"2025","unstructured":"Koestenberger, M., Eber, E., Pichler, G. & Sallmon, H. Bronchopulmonale-Dysplasie-assoziierte pulmonale Hypertonie. Monatsschr Kinderheilkd. 173, 733\u2013741 https:\/\/doi.org\/10.1007\/s00112-025-02260-3 (2025).","journal-title":"Monatsschr Kinderheilkd."},{"key":"5480_CR58","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-0038-1667378","volume":"36","author":"EJ Thompson","year":"2019","unstructured":"Thompson, E. J. et al. Sildenafil exposure in the neonatal intensive care unit. Am. J. Perinatol. 36, 262\u2013267 https:\/\/doi.org\/10.1055\/s-0038-1667378 (2019).","journal-title":"Am. J. Perinatol."},{"key":"5480_CR59","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/cpt.1990","volume":"109","author":"SN Salerno","year":"2021","unstructured":"Salerno, S. N. et al. Physiologically-based pharmacokinetic modeling characterizes the CYP3A-mediated drug-drug interaction between fluconazole and sildenafil in infants. Clin. Pharm. Ther. 109, 253\u2013262 https:\/\/doi.org\/10.1002\/cpt.1990 (2021).","journal-title":"Clin. Pharm. Ther."},{"key":"5480_CR60","doi-asserted-by":"publisher","first-page":"2401345","DOI":"10.1183\/13993003.01345-2024","volume":"64","author":"D Ivy","year":"2024","unstructured":"Ivy, D. et al. Embracing the challenges of neonatal and paediatric pulmonary hypertension. Eur. Respir. J. 64, 2401345 https:\/\/doi.org\/10.1183\/13993003.01345-2024 (2024).","journal-title":"Eur. Respir. J."},{"key":"5480_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/ph16040503","volume":"16","author":"CD Fike","year":"2023","unstructured":"Fike, C. D. & Aschner, J. L. Pharmacotherapy for pulmonary hypertension in infants with bronchopulmonary dysplasia: past, present, and future. Pharmaceuticals 16, 503 https:\/\/doi.org\/10.3390\/ph16040503 (2023).","journal-title":"Pharmaceuticals"},{"key":"5480_CR62","doi-asserted-by":"publisher","first-page":"e12320","DOI":"10.1002\/pul2.12320","volume":"13","author":"F H\u00e4fner","year":"2023","unstructured":"H\u00e4fner, F. et al. Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia-a survey study in Germany (PUsH BPD). Pulm. Circ. 13, e12320 https:\/\/doi.org\/10.1002\/pul2.12320 (2023).","journal-title":"Pulm. Circ."},{"key":"5480_CR63","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41372-022-01374-w","volume":"42","author":"H Sallmon","year":"2022","unstructured":"Sallmon, H. et al. Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension. J. Perinatol. J. Calif. Perinat. Assoc. 42, 781\u2013787 https:\/\/doi.org\/10.1038\/s41372-022-01374-w (2022).","journal-title":"J. Perinatol. J. Calif. Perinat. Assoc."},{"key":"5480_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.niox.2019.12.003","volume":"95","author":"J Dillard","year":"2020","unstructured":"Dillard, J., Perez, M. & Chen, B. Therapies that enhance pulmonary vascular NO-signaling in the neonate. Nitric Oxide Biol. Chem. 95, 45\u201354 https:\/\/doi.org\/10.1016\/j.niox.2019.12.003 (2020).","journal-title":"Nitric Oxide Biol. Chem."},{"key":"5480_CR65","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","volume":"38","author":"G Hansmann","year":"2019","unstructured":"Hansmann, G. et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J. Heart Lung Transplant. Publ. Int Soc. Heart Transpl. 38, 879\u2013901 https:\/\/doi.org\/10.1016\/j.healun.2019.06.022 (2019).","journal-title":"J. Heart Lung Transplant. Publ. Int Soc. Heart Transpl."},{"key":"5480_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10928-019-09654-3","volume":"46","author":"P Chanu","year":"2019","unstructured":"Chanu, P., Gao, X., Bruno, R., Claret, L. & Harnisch, L. A modeling and simulation-based assessment of the impact of confounding factors on the readout of a sildenafil survival trial in pulmonary arterial hypertension. J. Pharmacokinet. Pharmacodyn. 46, 499\u2013509 https:\/\/doi.org\/10.1007\/s10928-019-09654-3 (2019).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"5480_CR67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MOP.0000000000001383","volume":"36","author":"C Michel-Mac\u00edas","year":"2024","unstructured":"Michel-Mac\u00edas, C., H\u00e9bert, A. & Altit, G. Optimizing management of chronic pulmonary hypertension in preterm infants: strategies for a complex population. Curr. Opin. Pediatr. 36, 581\u2013590 https:\/\/doi.org\/10.1097\/MOP.0000000000001383 (2024).","journal-title":"Curr. Opin. Pediatr."},{"key":"5480_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5863\/1551-6776-23.2.100","volume":"23","author":"A De","year":"2018","unstructured":"De, A. et al. A retrospective review of infants receiving sildenafil. J. Pediatr. Pharm. Ther. JPPT J. Ppag. 23, 100\u2013105 https:\/\/doi.org\/10.5863\/1551-6776-23.2.100 (2018).","journal-title":"J. Pediatr. Pharm. Ther. JPPT J. Ppag."},{"key":"5480_CR69","doi-asserted-by":"publisher","first-page":"204589402110578","DOI":"10.1177\/20458940211057891","volume":"11","author":"I Jeremiasen","year":"2021","unstructured":"Jeremiasen, I. et al. Vasodilator therapy for pulmonary hypertension in children: a national study of patient characteristics and current treatment strategies. Pulm. Circ. 11, 20458940211057891 https:\/\/doi.org\/10.1177\/20458940211057891 (2021).","journal-title":"Pulm. Circ."},{"key":"5480_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2018.04.005","volume":"199","author":"D Aboudi","year":"2018","unstructured":"Aboudi, D. et al. Sildenafil and retinopathy of prematurity in preterm infants with bronchopulmonary dysplasia. J. Pediatr. 199, 16\u201321 https:\/\/doi.org\/10.1016\/j.jpeds.2018.04.005 (2018).","journal-title":"J. Pediatr."},{"key":"5480_CR71","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/01902148.2021.1976311","volume":"47","author":"S Katsuragi","year":"2021","unstructured":"Katsuragi, S. et al. Riociguat can ameliorate bronchopulmonary dysplasia in the SU5416 induced rat experimental model. Exp. Lung Res. 47, 382\u2013389 https:\/\/doi.org\/10.1080\/01902148.2021.1976311 (2021).","journal-title":"Exp. Lung Res."},{"key":"5480_CR72","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1203\/PDR.0b013e31817d9a2c","volume":"64","author":"R Tessler","year":"2008","unstructured":"Tessler, R. et al. Sildenafil acutely reverses the hypoxic pulmonary vasoconstriction response of the newborn pig. Pediatr. Res. 64, 251\u2013255 https:\/\/doi.org\/10.1203\/PDR.0b013e31817d9a2c (2008).","journal-title":"Pediatr. Res."},{"key":"5480_CR73","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.3390\/cells10102766","volume":"10","author":"M Zinni","year":"2021","unstructured":"Zinni, M., Pansiot, J., L\u00e9ger, P. L., El Kamouh, M. & Baud, O. Sildenafil-mediated neuroprotection from adult to neonatal brain injury: evidence, mechanisms, and future translation. Cells 10, 2766 https:\/\/doi.org\/10.3390\/cells10102766 (2021).","journal-title":"Cells"},{"key":"5480_CR74","doi-asserted-by":"publisher","first-page":"e70212","DOI":"10.1002\/pul2.70212","volume":"15","author":"R Saggar","year":"2025","unstructured":"Saggar, R. et al. A systematic literature review exploring the efficacy and safety of tadalafil and sildenafil in pulmonary arterial hypertension. Pulm. Circ. 15, e70212 https:\/\/doi.org\/10.1002\/pul2.70212 (2025).","journal-title":"Pulm. Circ."},{"key":"5480_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/children8020131","volume":"8","author":"S Lakshminrusimha","year":"2021","unstructured":"Lakshminrusimha, S. Neonatal and postneonatal pulmonary hypertension. Children 8, 131 https:\/\/doi.org\/10.3390\/children8020131 (2021).","journal-title":"Children"},{"key":"5480_CR76","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00431-021-04355-x","volume":"181","author":"A Pels","year":"2022","unstructured":"Pels, A. et al. Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study. Eur. J. Pediatr. 181, 1709\u20131718 https:\/\/doi.org\/10.1007\/s00431-021-04355-x (2022).","journal-title":"Eur. J. Pediatr."},{"key":"5480_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00431-024-05843-6","volume":"184","author":"M Takeoka","year":"2024","unstructured":"Takeoka, M. et al. Persistent pulmonary hypertension in children after apparent resolution of ultrasound-defined pulmonary hypertension associated with bronchopulmonary dysplasia. Eur. J. Pediatr. 184, 26 https:\/\/doi.org\/10.1007\/s00431-024-05843-6 (2024).","journal-title":"Eur. J. Pediatr."},{"key":"5480_CR78","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/apa.16615","volume":"112","author":"I Jeremiasen","year":"2023","unstructured":"Jeremiasen, I., Tran-Lundmark, K., Dolk, M. & Naumburg, E. Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia. Acta Paediatr. 112, 409\u2013416 https:\/\/doi.org\/10.1111\/apa.16615 (2023).","journal-title":"Acta Paediatr."},{"key":"5480_CR79","doi-asserted-by":"publisher","unstructured":"Bamat N. et al. Pulmonary vasodilator use in very preterm infants in United States children\u2019s hospitals. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-5492163\/v1 (2024).","DOI":"10.21203\/rs.3.rs-5492163\/v1"},{"key":"5480_CR80","doi-asserted-by":"publisher","first-page":"1077422","DOI":"10.3389\/fped.2023.1077422","volume":"11","author":"D Yung","year":"2023","unstructured":"Yung, D. et al. A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension. Front. Pediatr. 11, 1077422 https:\/\/doi.org\/10.3389\/fped.2023.1077422 (2023).","journal-title":"Front. Pediatr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05480-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05480-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:20:08Z","timestamp":1790709608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05480-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":80,"alternative-id":["5480"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05480-9","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This is a narrative review; therefore, ethics approval was not required as no human or animal subjects were directly involved.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}